NCT04756479

Mortality Due to COVID-19 in the COVID-AGEBRU Study

Predictors of Intrahospital Mortality in Older Patients Admitted Due to COVID-19 in the COVID-19 AGEBRU Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 160 (actual)
• Sponsor: Brugmann University Hospital · Academic / Other
• Sex: All
• Age: 70 Years
• Healthy volunteers: Not accepted

Summary

The COVID-Age Brugmann study aims to identify the clinical predictors of mortality risk in older patients admitted to an acute care unit due to COVID-19

Detailed description

The COVID-19 disease has been shown to be associated to higher mortality risk and health adverse consequences. Despite of the fact that the SAR-COV2 virus has been shown that affects every populations, the negative impact is higher in older people, pointing this population as the most severely affected. The COVID-Age Brugmann study aims to identify if comorbidity, geriatric syndromes, and health issues at admission are associated to mortality risk in older patients admitted to an acute care unit due to COVID-19

Conditions

• Covid19
• Old Age; Debility
• Morbidity, Multiple

Timeline

• Start date: 2020-03-01
• Primary completion: 2020-06-30
• Completion: 2020-06-30
• First posted: 2021-02-16
• Last updated: 2022-04-06

Locations

1 site across 1 country: Belgium